Structural Variants in COL1A1 and COL1A2 in Osteogenesis Imperfecta
Open Access
- 8 November 2024
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 197 (3) , e63935
Abstract
Osteogenesis Imperfecta (OI) is a heterogeneous skeletal dysplasia characterized by bone fragility, skeletal deformities, and short stature. Most commonly, it is caused by autosomal dominant variants in the type I collagen genes, COL1A1 or COL1A2. Type I collagen is the main protein of the extracellular matrix in the skeleton and changes in its structure or quantity may lead to OI. 85%–90% of OI cases occur due to sequence variants in type I collagen genes, while OI caused by structural abnormalities in type I collagen genes is less common. In most cases, haploinsufficiency of type I collagen is associated with a milder OI phenotype. Large genomic deletions often involve several genes within the same chromosomal region, leading to microdeletion syndromes with OI features. Here, we report eight Swedish patients from five unrelated families with OI due to structural variants in the COL1A1 and COL1A2 genes. One patient with OI type III had a complex rearrangement with a deletion and duplication event in COL1A2, leading to reduced COL1A2 expression. Three other patients from two different families with OI type I had whole gene deletions involving COL1A1. In one family, three affected individuals with OI type I had a small intragenic deletion of exons 11–12 in COL1A2. One patient had a 2.1 Mb de novo deletion encompassing COL1A1 and DLX3 genes and features of OI and tricho‐dento‐osseous syndrome. Overall, this study highlights the importance of investigating gene dosage abnormalities in patients with OI and further delineates clinical and genetic variability of OI caused by structural variants in type I collagen genes.Keywords
Funding Information
- Stiftelsen Frimurare Barnhuset i Stockholm
- Stiftelsen Promobilia
- Vetenskapsrådet
- Sällskapet Barnavård
- Karolinska Institutet
- Bertil Hållstens Forskningsstiftelse
This publication has 30 references indexed in Scilit:
- Nosology of genetic skeletal disorders: 2023 revisionAmerican Journal of Medical Genetics Part A, 2023
- Exome Sequencing Reveals a Phenotype Modifying Variant in ZNF528 in Primary Osteoporosis With a COL1A2 DeletionJournal of Bone and Mineral Research, 2020
- A 235 Kb deletion at 17q21.33 encompassing theCOL1A1, and two additional secondary copy number variants in an infant with type I osteogenesis imperfecta: A rare case reportMolecular Genetics & Genomic Medicine, 2020
- De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental DisordersThe American Journal of Human Genetics, 2020
- Alu-Alu mediated intragenic duplications in IFT81 and MATN3 are associated with skeletal dysplasiasHuman Mutation, 2018
- Osteogenesis Imperfecta Type I Caused by COL1A1 DeletionsCalcified Tissue International, 2015
- Osteogenesis imperfecta, tricho‐dento‐osseous syndrome and intellectual disability: A familial case with 17q21.33‐q22 (COL1A1 and DLX3) deletion and 7q32.3‐q33 duplication resulting from a reciprocal interchromosomal insertionAmerican Journal of Medical Genetics Part A, 2013
- A 4 bp deletion mutation in DLX3 enhances osteoblastic differentiation and bone formation in vitroBone, 2008
- Increased bone density associated with DLX3 mutation in the tricho-dento-osseous syndromeBone, 2004
- Heterozygosity for a large deletion in the alpha 2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta.Journal of Biological Chemistry, 1988